JP2018506534A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506534A5
JP2018506534A5 JP2017541934A JP2017541934A JP2018506534A5 JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5 JP 2017541934 A JP2017541934 A JP 2017541934A JP 2017541934 A JP2017541934 A JP 2017541934A JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5
Authority
JP
Japan
Prior art keywords
ghr
stat5
socs
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541934A
Other languages
English (en)
Japanese (ja)
Other versions
JP6930916B2 (ja
JP2018506534A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/017717 external-priority patent/WO2016130901A2/en
Publication of JP2018506534A publication Critical patent/JP2018506534A/ja
Publication of JP2018506534A5 publication Critical patent/JP2018506534A5/ja
Application granted granted Critical
Publication of JP6930916B2 publication Critical patent/JP6930916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541934A 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤 Active JP6930916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562115356P 2015-02-12 2015-02-12
US62/115,356 2015-02-12
PCT/US2016/017717 WO2016130901A2 (en) 2015-02-12 2016-02-12 Blockers of the growth hormone receptor in disease prevention and treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021018032A Division JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Publications (3)

Publication Number Publication Date
JP2018506534A JP2018506534A (ja) 2018-03-08
JP2018506534A5 true JP2018506534A5 (enExample) 2019-03-28
JP6930916B2 JP6930916B2 (ja) 2021-09-01

Family

ID=56615057

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017541934A Active JP6930916B2 (ja) 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Country Status (14)

Country Link
US (2) US10246446B2 (enExample)
EP (1) EP3256465B1 (enExample)
JP (2) JP6930916B2 (enExample)
KR (1) KR20180016333A (enExample)
CN (1) CN107438605B (enExample)
AU (1) AU2016219173B2 (enExample)
BR (1) BR112017017182A2 (enExample)
CA (1) CA2976219C (enExample)
ES (1) ES2871551T3 (enExample)
IL (1) IL253943A0 (enExample)
MX (1) MX383010B (enExample)
NZ (1) NZ734252A (enExample)
RU (1) RU2726254C2 (enExample)
WO (1) WO2016130901A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
AU2019236242A1 (en) 2018-03-15 2020-10-01 University Of Southern California Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology
TW202600604A (zh) * 2024-04-30 2026-01-01 大陸商長春金賽藥業有限責任公司 Ghr激動型抗體及其應用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701010D0 (sv) * 1997-03-19 1997-03-19 Pharmacia & Upjohn Ab Antibody
JPWO2002096892A1 (ja) 2001-05-31 2004-09-09 小野薬品工業株式会社 オキサジアゾール誘導体化合物およびその化合物を有効成分とする薬剤
WO2006001770A1 (en) * 2004-06-28 2006-01-05 Biovitrum Ab Method for identifying modulators of cytokine class i receptor
RU2415134C9 (ru) * 2005-08-15 2011-05-27 Этерна Центарис ГмбХ Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе
JP5555169B2 (ja) * 2007-10-11 2014-07-23 バーテックス ファーマシューティカルズ インコーポレイテッド 電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド
NZ587632A (en) * 2008-03-14 2012-06-29 Biocon Ltd An anti-cd6 monoclonal antibody and a method thereof
EP2460394B1 (en) * 2009-07-28 2013-06-05 Koninklijke Philips Electronics N.V. Housing with locking structure
JP2015502975A (ja) * 2011-12-22 2015-01-29 ライナット ニューロサイエンス コーポレイション ヒト成長ホルモン受容体アンタゴニスト抗体およびその使用方法
CN104334541A (zh) * 2012-02-16 2015-02-04 纽约大学 使用低聚氧代哌嗪非肽螺旋模拟物对低氧诱导基因表达的控制
US9732067B2 (en) * 2012-06-20 2017-08-15 University Of Kansas Compounds and methods for activating the apoptotic arm of the unfolded protein response
US9237761B2 (en) 2013-02-12 2016-01-19 University Of Southern California Methods and diets for lowering glucose and/or IGF-1 levels

Similar Documents

Publication Publication Date Title
JP2016040288A5 (enExample)
JP2016505637A5 (enExample)
JP2016528301A5 (enExample)
JP2020097577A5 (enExample)
JP2015524472A5 (enExample)
JP2016515561A5 (enExample)
JP2016503797A5 (enExample)
JP2017511377A5 (enExample)
JP2016536286A5 (enExample)
JP2017528503A5 (enExample)
JP2019515908A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2014528464A5 (enExample)
JP2016508134A5 (enExample)
JP2013518107A5 (enExample)
JP2012513416A5 (enExample)
JP2020507589A5 (enExample)
JP2014505107A5 (enExample)
JP2012255002A5 (enExample)
JP2016515628A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
JP2019520344A5 (enExample)
JP2019535723A5 (enExample)
JP2015521156A5 (enExample)
JP2010521516A5 (enExample)